Literature DB >> 8733124

Gene transfer into the mouse retina mediated by an adeno-associated viral vector.

R R Ali1, M B Reichel, A J Thrasher, R J Levinsky, C Kinnon, N Kanuga, D M Hunt, S S Bhattacharya.   

Abstract

Gene transfer to photoreceptor cells may provide a means for arresting the retinal degeneration that is characteristic of many inherited causes of blindness, including retinitis pigmentosa (RP). However, transduction of photoreceptors has to date been inefficient, and further limited by toxicity and immune responses directed against vector-specific proteins. An alternative vector system based on adeno-associated virus (AAV) may obviate these problems, and may be useful for transduction of neuronal cells. In this study we have demonstrated successful transduction of all layers of the neuroretina as well as the retinal pigment epithelium (RPE) following subretinal injection of recombinant AAV particles encoding lac Z. Furthermore, the efficiency of transduction of photoreceptors is significantly higher than that achieved with an equivalent adenoviral vector. This is the first report showing that AAV is capable of transducing photoreceptor cells and supports the use of this vector system for gene therapy of retinal diseases such as RP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733124     DOI: 10.1093/hmg/5.5.591

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

1.  Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.

Authors:  J Bennett; A M Maguire; A V Cideciyan; M Schnell; E Glover; V Anand; T S Aleman; N Chirmule; A R Gupta; Y Huang; G P Gao; W C Nyberg; J Tazelaar; J Hughes; J M Wilson; S G Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination.

Authors:  J Yang; W Zhou; Y Zhang; T Zidon; T Ritchie; J F Engelhardt
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  AAV gene transfer to the retina does not protect retrovirally transduced hepatocytes from the immune response.

Authors:  Marta Bellodi-Privato; Guylène Le Meur; Dominique Aubert; Alexandra Mendes-Madera; Virginie Pichard; Fabienne Rolling; Nicolas Ferry
Journal:  J Mol Med (Berl)       Date:  2004-03-24       Impact factor: 4.599

Review 4.  What Is Next for Retinal Gene Therapy?

Authors:  Luk H Vandenberghe
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

Review 5.  [Viral and nonviral gene therapy for treatment of retinal diseases].

Authors:  J Neidhardt; K Wycisk; B Klöckener-Gruissem
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

Review 6.  Channelrhodopsins provide a breakthrough insight into strategies for curing blindness.

Authors:  Hiroshi Tomita; Eriko Sugano; Hitomi Isago; Makoto Tamai
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

7.  Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey.

Authors:  Luk H Vandenberghe; Peter Bell; Albert M Maguire; Cassia N Cearley; Ru Xiao; Roberto Calcedo; Lili Wang; Michael J Castle; Alexandra C Maguire; Rebecca Grant; John H Wolfe; James M Wilson; Jean Bennett
Journal:  Sci Transl Med       Date:  2011-06-22       Impact factor: 17.956

8.  Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors.

Authors:  Mei Hong Tan; Alexander J Smith; Basil Pawlyk; Xiaoyun Xu; Xiaoqing Liu; James B Bainbridge; Mark Basche; Jenny McIntosh; Hoai Viet Tran; Amit Nathwani; Tiansen Li; Robin R Ali
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

Review 9.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886

Review 10.  Promising and delivering gene therapies for vision loss.

Authors:  Livia S Carvalho; Luk H Vandenberghe
Journal:  Vision Res       Date:  2014-08-02       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.